Frontlight ResearchEarly access
CompletedNo phase
A Case Report of NMDAR Encephalopathy
Key facts
- Who runs it
- Mayo Clinic
- Where
- Jacksonville, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 1 person enrolled
- Started
- 20 Jun 2024
- Ended
- 19 Dec 2024
- Type of study
- Observational
- Treatments tested
- Magnetic Resonance Imaging (MRI)
- Salpingo-oophorectomy
- Record updated
- 8 April 2025
Who can take part
- Age
- 34 years to 34 years
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Suspected Anti-NMDA Encephalitis
Who cannot take part
- Inability to consent
Where in United States
- Mayo Clinic in FloridaJacksonville, United States
About the trial
What the trial wants to find out
This case illustrates the clinical, radiologic, and histopathologic features of Anti-NMDAR encephalitis and underscores the importance of MRI in detecting ovarian teratomas when pelvic ultrasound is inconclusive.
Treatments tested
- Magnetic Resonance Imaging (MRI)
- Salpingo-oophorectomy
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 8 April 2025